Cresemba (isavuconazonium sulfate) - Astellas, Basilea
Prevymis (letermovir) - Merck (MSD)
Letermovir coadministration and tacrolimus concentration-to-dose ratios before and after intravenous-to-oral conversion in allogeneic hematopoietic stem cell transplant recipients receiving isavuconazole. (PubMed, Jpn J Clin Oncol) - Aug 19, 2026 - "Sensitivity analyses yielded consistent findings. Letermovir coadministration was not associated with significant differences in tacrolimus C/D ratios pre- or post-conversion to oral administration in allogeneic HCT recipients receiving isavuconazole." 
Journal • Bone Marrow Transplantation • Cytomegalovirus Infection • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/42611513
 
Ayumu Ito; Hironobu Hashimoto; Takahiro Fukuda; Toshihisa Nakashima; Yoshihiro Inamoto
 
Aug 19, 2026
 
Prev Next